CITY THERAPEUTICS ANNOUNCES FIRST PARTICIPANT DOSED IN PHASE 1 CLINICAL TRIAL OF CITY-RBP4 FOR THE TREATMENT OF STARGARDT DISEASE

Reuters · 1d ago

Please log in to view news